Politics
FDA Advances Peptide Policy to White House
The FDA has submitted a peptide ‘interim access policy’ to the White House for review. This move is part of ongoing efforts to advance healthcare policies and could have significant implications for public health.
Coverage timeline — 1 article
The Hill
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a government filing, which wo
2026-10-15 23:50 UTC